| 摘要 |
<p>A method of treating neoplasias, including female mammalian neoplasias such as breast, cervical, uterine, and ovarian neoplasias, as well as other neoplasias including prostatic, dermal, and bronchogenic cancers, comprising delivery of an effective non-naturally occurring, non-cytologically proliferative lytic peptide to an appropriate corporeal site to effectively treat such disease. Particularly preferred lytic peptide agents include small (22-39 amino acids) amphipathic cationic lytic peptides from the classes of synthetic analog derivatives of melittin, cecropin, magainin, and defensin peptides, most preferably melittin and defensin peptides from the class of synthetic analogs of melittin, cecropin, magainin, and defensin peptides, most preferably synthetic analogs of melittin and defensin peptides.</p> |
